Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC
Key facts
- Who runs it
- Pharmicell Co., Ltd.
- Where
- South Korea14 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 9 Sept 2021
- Expected to end
- 31 Dec 2031
- Type of study
- Observational
- Record updated
- 21 September 2026
Who can take part
- Age
- 19 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Participants who received Cellgram-LC in the PMC-P-07 clinical trial
- Participants who voluntarily provide written informed consent to participate in this study
Who cannot take part
- None
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 70 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this observational study is to learn about the long-term safety of Cellgram-LC in patients with alcoholic liver cirrhosis who previously received Cellgram-LC in the PMC-P-07 study.
Read full original descriptionShow less
The main question it aims to answer is:
- Do adverse event of special interest (AESI) or liver transplantation occur during the 5 years after Cellgram-LC administration?
Participants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily consent to participate in this long-term follow-up study will be followed for 5 years after Cellgram-LC administration through telephone visits to collect information on AESI and liver transplantation.
The group in the trial
- Cellgram-LC-treated Participants
Participants who previously received Cellgram-LC in the PMC-P-07 study and voluntarily provide written informed consent to participate in this long-term follow-up study.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
- Fit questions
- Built from NCT05093881, who can take part
- Record updated
- 21 September 2026